Epilepsy

What is Epilepsy?

Epilepsy is a chronic neurological disorder characterized by recurrent, unprovoked seizures caused by abnormal electrical activity in the brain. It affects people of all ages, races, and socioeconomic backgrounds worldwide. Epilepsy is one of the most common neurological conditions globally, affecting approximately 65 million people. A person is typically diagnosed with epilepsy after experiencing two or more unprovoked seizures occurring at least 24 hours apart.

Key statistics

Global prevalence:	65 million people worldwide
Annual incidence:	40-70 per 100,000 people
Age of onset:	Peaks in children under 2 years and adults over 65
Mortality:	2-3 times higher than general population

Symptoms

Epilepsy symptoms vary widely depending on seizure type: convulsions, temporary confusion, staring spells, loss of consciousness, uncontrollable jerking movements, altered awareness, unusual sensations, and automatic behaviors.

Focal seizures affect one area of the brain and may cause altered emotions, sensory changes, involuntary movements of one body part, or déjà vu sensations. Simple focal seizures maintain consciousness, while complex focal seizures impair awareness and may cause staring, lip smacking, or repetitive hand movements.

Generalized seizures involve the entire brain. Absence seizures cause brief staring spells and subtle body movements, primarily in children. Tonic seizures cause muscle stiffening, while clonic seizures involve rhythmic jerking. Tonic-clonic seizures combine both phases and may include tongue biting and loss of bladder control. Myoclonic seizures cause sudden muscle jerks, and atonic seizures result in sudden loss of muscle tone, causing falls.

Status epilepticus is a medical emergency involving prolonged seizures lasting more than five minutes or repeated seizures without regaining consciousness.

Causes and risk factors

Epilepsy has multiple potential causes, though the underlying cause remains unknown in approximately 50% of cases. Genetic factors play a role in many epilepsies, with over 500 genes associated with the condition. Structural abnormalities include brain tumors, strokes, traumatic brain injuries, infections like meningitis or encephalitis, and developmental malformations.

Metabolic causes encompass conditions affecting brain chemistry, while immune-mediated epilepsies result from autoimmune attacks on brain tissue. Infectious causes include parasitic infections, viral encephalitis, and bacterial meningitis.

Risk factors include family history of epilepsy, head trauma, stroke, brain infections, prolonged febrile seizures in childhood, and certain genetic syndromes. Age is also significant, with higher risks in infancy and after age 60. Prenatal factors such as maternal infection, poor nutrition, or oxygen deficiency can increase risk.

Prevention

Primary prevention focuses on reducing risk factors for acquired epilepsy. Preventing head injuries through proper safety equipment, seatbelt use, and fall prevention reduces traumatic brain injury risk. Prompt treatment of infections that can affect the brain, such as meningitis and encephalitis, is crucial. Managing cardiovascular risk factors helps prevent strokes that could lead to epilepsy.

Vaccination programs against infections like Japanese encephalitis and proper prenatal care reduce epilepsy risk. For individuals with known genetic risk factors, genetic counseling provides valuable information for family planning decisions. While genetic forms cannot be prevented, early detection through genetic screening helps families prepare for potential challenges and access appropriate medical care.

Complications

Untreated or poorly controlled epilepsy can lead to serious complications. Sudden unexpected death in epilepsy (SUDEP) affects 1 in 1,000 people with epilepsy annually, with higher risks in those with frequent tonic-clonic seizures and poor seizure control.

Physical injuries from falls during seizures can cause fractures, head trauma, and burns. Cognitive effects may include memory problems, attention difficulties, and learning challenges, particularly with frequent seizures or certain medications.

Psychological complications are common, with depression affecting 20-30% of people with epilepsy and anxiety disorders occurring in 15-25%. Social consequences include driving restrictions, employment limitations, and social stigma. Status epilepticus can cause permanent brain damage or death if not treated promptly.

Diagnosis

Epilepsy diagnosis relies primarily on clinical history and witness accounts of seizure events. Electroencephalography (EEG) records brain electrical activity and may show abnormal patterns supporting the diagnosis. Video-EEG monitoring captures seizures while recording brain waves, providing definitive diagnosis.

Magnetic resonance imaging (MRI) identifies structural brain abnormalities that might cause seizures. Blood tests check for metabolic causes, genetic markers, and medication levels. Lumbar puncture may be performed if infection is suspected.

Neuropsychological testing evaluates cognitive function and can help localize seizure origins. Genetic testing is increasingly used, especially in children with unexplained epilepsy. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) may be used in complex cases to identify seizure sources.

Treatment

Treatment aims to achieve seizure freedom while minimizing side effects. Antiepileptic drugs (AEDs) are the primary treatment, with medication choice based on seizure type, age, and individual factors.

First-line medications include levetiracetam, carbamazepine, lamotrigine, and valproic acid. Newer options include lacosamide, perampanel, and brivaracetam.

Surgical options are considered for drug-resistant epilepsy. Procedures include focal resection, corpus callosotomy, and hemispherectomy. Neurostimulation devices such as vagus nerve stimulation, responsive neurostimulation, and deep brain stimulation offer alternatives for inoperable cases.

Dietary therapies include the ketogenic diet, modified Atkins diet, and low glycemic index treatment, particularly effective in children with certain epilepsy syndromes.

Prognosis

Approximately 70% of people with epilepsy can achieve seizure freedom with appropriate treatment. Early diagnosis and proper medication management significantly improve outcomes. About 30% develop drug-resistant epilepsy, requiring alternative treatments or surgical intervention.

With optimal treatment, many individuals with epilepsy live normal lifespans with good quality of life. However, life expectancy may be reduced in cases with severe, uncontrolled seizures or underlying progressive neurological conditions. Factors affecting prognosis include seizure type, underlying cause, age of onset, and response to initial treatment.

Children with certain epilepsy syndromes may outgrow their condition, while others require lifelong management. Early seizure control is associated with better long-term cognitive and social outcomes.

Quality of life

Living with epilepsy requires lifestyle adjustments to optimize seizure control and safety. Medication adherence is crucial, requiring consistent timing and avoiding missed doses. Sleep hygiene is essential, as sleep deprivation is a common seizure trigger.

Exercise is generally encouraged but should be supervised for activities like swimming. Stress management through relaxation techniques, counseling, or support groups helps reduce seizure triggers. Dietary considerations may include avoiding alcohol and maintaining stable blood sugar levels.

Safety measures include shower chairs, protective helmets if needed, and avoiding heights or dangerous machinery. Seizure action plans help family and friends respond appropriately during seizures. Mental health support addresses depression and anxiety commonly associated with epilepsy.

Educational and workplace accommodations may include flexible scheduling, safety modifications, and understanding from teachers or employers. Support groups provide valuable peer connections and practical advice.

Pregnancy and fertility

Women with epilepsy can have successful pregnancies with proper planning and monitoring. Preconception counseling is essential to optimize medication regimens and discuss risks. Some antiepileptic drugs increase birth defect risks, particularly valproic acid, which should be avoided if possible in women of childbearing age.

Folic acid supplementation (5mg daily) is recommended before conception and throughout pregnancy. Medication adjustments may be necessary due to physiological changes affecting drug metabolism. Regular monitoring includes medication levels and fetal development assessments.

Labor and delivery usually proceed normally, though seizure precautions should be in place. Breastfeeding is generally encouraged, as most antiepileptic drugs pass into breast milk in small amounts. Genetic counseling helps families understand inheritance patterns and recurrence risks.

Children

Childhood epilepsy presents unique challenges requiring specialized care. Developmental considerations include the impact of seizures and medications on learning, behavior, and social development. School accommodations may include seizure action plans, medication administration, and educational support.

Age-specific syndromes include infantile spasms, Lennox-Gastaut syndrome, and childhood absence epilepsy, each requiring tailored treatment approaches. Cognitive monitoring is important as seizures and medications can affect learning and memory.

Family support and education help parents manage the condition effectively. Transition planning to adult care typically begins in adolescence, ensuring continuity of care and developing self-management skills. Vaccination schedules should be maintained, though fever prevention strategies may be implemented.

When to see a doctor

Seek immediate emergency care for seizures lasting more than 5 minutes, difficulty breathing or waking after a seizure, injuries sustained during a seizure, or seizures occurring in someone without known epilepsy. Multiple seizures without full recovery between episodes also require emergency attention.

Schedule routine medical care for medication side effects, breakthrough seizures in someone with controlled epilepsy, or concerns about seizure control. Regular follow-up appointments are essential for medication monitoring, side effect assessment, and seizure diary review.

Women planning pregnancy should consult their neurologist for preconception counseling and medication optimization.

Regional context

Limited data exists on epilepsy prevalence specifically in the Caucasus region, though studies suggest prevalence rates similar to global averages. Healthcare access and epilepsy management vary across Georgia, Armenia, and Azerbaijan, with urban centers generally offering more specialized neurological care than rural areas.

Treatment availability, particularly newer antiepileptic drugs and surgical options, may be limited in some regions. Genetic testing and advanced diagnostic procedures may require referral to specialized centers. GMJ welcomes contributions from regional researchers to build the evidence base for epilepsy in the Caucasus.

Research and clinical trials

Current epilepsy research focuses on precision medicine approaches, identifying genetic biomarkers for treatment selection, and developing new therapeutic targets. Gene therapy trials show promise for specific genetic epilepsies. Advanced neurostimulation techniques and closed-loop systems that predict and prevent seizures are in development.

Biomarker research aims to identify predictors of treatment response and seizure recurrence. Digital health technologies including seizure detection devices and smartphone applications are being validated. Active clinical trials can be found at ClinicalTrials.gov, offering opportunities for patients with drug-resistant epilepsy to access experimental treatments.

Frequently asked questions

Is epilepsy hereditary?

Genetics play a role in many epilepsies, but most cases are not directly inherited. The risk of epilepsy in children of affected individuals is generally 4-8%, compared to 1-2% in the general population.

Can people with epilepsy drive?

Driving regulations vary by location but typically require a seizure-free period ranging from 3-12 months. Some jurisdictions allow driving with certain seizure types that don’t impair consciousness or motor function.

Do all people with epilepsy need lifelong treatment?

Not necessarily. Some childhood epilepsy syndromes resolve with age, and seizure-free adults may consider medication withdrawal under medical supervision after 2-5 years without seizures.

Are seizures always convulsive?

No. Many seizures involve subtle symptoms like staring, confusion, or unusual sensations without visible convulsions. These non-convulsive seizures can be equally disruptive.

Can stress cause seizures?

Yes, stress is a common seizure trigger. However, stress management and relaxation techniques can help reduce seizure frequency in stress-sensitive individuals.

Support and resources

International League Against Epilepsy (ILAE) – www.ilae.org – provides evidence-based guidelines and educational resources.

Epilepsy Foundation – www.epilepsy.com – offers patient education, advocacy, and support services.

International Bureau for Epilepsy (IBE) – www.ibe-epilepsy.org – focuses on social aspects and patient advocacy.

World Health Organization – www.who.int – provides global epilepsy statistics and public health initiatives.

Citizens United for Research in Epilepsy (CURE) – www.cureepilepsy.org – funds research and provides patient resources.

Related conditions

Febrile seizures – seizures triggered by fever in young children, usually benign but may increase epilepsy risk.

Non-epileptic seizures – seizure-like episodes not caused by abnormal brain electrical activity, often related to psychological factors.

Migraine – shares some genetic factors with epilepsy and can occasionally be confused with certain seizure types.

Autism spectrum disorder – co-occurs with epilepsy in approximately 20-25% of cases, particularly in individuals with intellectual disability.

Tuberous sclerosis – genetic condition causing benign tumors and frequently associated with epilepsy, affecting 80-90% of patients.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, UpToDate, relevant EULAR/ACR/WHO guidelines. This article is for informational purposes only and does not constitute medical advice. Content licensed under CC BY 4.0.

Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.